|
|
 Global Information - January 8, 2009
| Sydney, Australia (AHN)-Scientists are accusing major pharmaceutical firms of "medicalizing" problems like high cholesterol or the symptoms of menopause in a bid to increase profits | | Indian researchers have taken a global lead in cracking the genetic causes for a form of chronic pancreatitis. They have identified two genes responsible for the disease, which is spreading across several States in India and South Asia. Researchers from the Center for Cellular and Molecular Biology (CCMB) and the Asian Institute of Gastroentorology (AIG), say mutations in SPINK1 and Cathepsin B genes can lead to the disease | | The World Health Organization (WHO) cites a health worker shortage of about four million health around the world. According to its report, fifty-seven countries have a serious shortage of health workers, affecting children's jabs, pregnancy care and access to treatment | | An Indian group of people living with HIV/AIDS have opposed a patent application filed by global pharma major GlaxoSmithKline for Combivir - a fixed-dose combination of two AIDS drugs (zidovudine/lamivudine, or AZT/3TC), on the grounds that it would make the treatment unaffordable. Represented by the Lawyers' Collective HIV/AIDS Unit, the Indian Network of People Living with HIV/AIDS and the Manipur Network of Positive People on Thursday officially submitted their opposition to a patent application filed at the Kolkata patent office by GlaxoSmithKline | | GlaxoSmithKline Plc's prescription drug, Relenza, is now approved to prevent influenza in adults and children ages 5 and older. According to Reuters, Relenza joins Roche AG's Tamiflu as the only other drug with Food and Drug Administration clearance for both prevention and treatment of the flu | |
|
|
